Role of vascular endothelial growth factor receptor-3 in early-stage cervical cancer.
Li Nan,Yu Hao,Zhang Shiqian
DOI: https://doi.org/10.13283/j.cnki.xdfckjz.2010.08.013
2010-01-01
Abstract:Objective:To investigate the role of vascular endothelial growth factor receptor(VEGFR)-3 in the early stages of cervical cancer.Methods:The expression of VEGFR-3,vascular endothelial growth factor(VEGF)-C,and VEGF-D in the early stages(ⅠA～ⅡA) of cervical cancer in 41 patients were detected by immunohistochemical analysis,the VEGFR-3-marked vascular density(MVD) was also examined and the relationship between these factors and clinical/pathological features was analyzed.Results:VEGFR-3 was found to be expressed in lymphatic endothelial cells and,to a certain extent,in vascular endothelial cells.The VEGFR-3-positive vessels were mostly distributed in the stroma surrounding the tumor tissues,and these vessels were morphologically divided in blood vessels and lymphatic vessels,respectively.Cancer cells were found to express VEGF-C,VEGF-D,and VEGFR-3,and their positive expression rate was 48.7%(20/41),58.5%(24/41),and 63.4%(26/41),respectively.The VEGFR-3 expression in the cancer cells of cervical cancer patients was found to be correlated with the clinical stage,lymph node metastasis,lymphatic invasion,and expressions of VEGF-C and VEGF-D,but unrelated to the menstrual status,histological grading,and histological classification.MVD was correlated with the clinical stage,expressions of VEGF-C and VEGF-D,and unrelated to the menstrual status,histological grading,histological classification,lymph node metastasis,and lymphatic invasion.Conclusion:VEGFR-3 may play an important role in malignant progression of early stages of cervical cancer by promoting angiogenesis and lymphangiogenesis.